Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
688336.SSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
167
Cost of Revenue
43
Gross Profit
124
Gross Margin
74.5%
Operating Income
102
Operating Margin
60.9%
Net Income
99
Net Margin
59.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
47
EBITDA Margin
28.0%
2023
12/31/2023
Revenue
142
Cost of Revenue
31
Gross Profit
111
Gross Margin
78.0%
Operating Income
45
Operating Margin
31.4%
Net Income
41
Net Margin
29.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
40
EBITDA Margin
28.3%
2022
12/31/2022
Revenue
116
Cost of Revenue
29
Gross Profit
87
Gross Margin
75.2%
Operating Income
5
Operating Margin
4.5%
Net Income
7
Net Margin
6.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
12
EBITDA Margin
10.3%
2021
12/31/2021
Revenue
130
Cost of Revenue
29
Gross Profit
101
Gross Margin
77.4%
Operating Income
-6
Operating Margin
-4.7%
Net Income
3
Net Margin
1.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
4
EBITDA Margin
2.9%
2020
12/31/2020
Revenue
92
Cost of Revenue
14
Gross Profit
77
Gross Margin
84.4%
Operating Income
-28
Operating Margin
-31.0%
Net Income
-30
Net Margin
-33.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-17
EBITDA Margin
-18.5%